Insights

Innovative Research Focus Prelude Therapeutics specializes in precision oncology with a pipeline centered around targeted protein degradation and novel cancer therapeutics, indicating a need for advanced laboratory, analytical, and biotech tools to support cutting-edge drug development.

Growing Workforce With over 50 employees and significant job performance grants aimed at doubling its staff, Prelude is expanding rapidly, creating opportunities for staffing solutions, HR services, and specialized recruitment technologies.

Active Industry Engagement Regular participation in major conferences such as AACR and global healthcare events highlights the company's focus on industry visibility and collaboration, opening avenues for networking, sponsorship, and partnership opportunities.

Funding and Development Recent financing awards and ongoing investments in preclinical drugs suggest a need for advanced research equipment, data management systems, and laboratory infrastructure upgrades to accelerate product pipelines.

Technology Adoption Utilizing advanced tech stacks including cloud management and analytics tools, Prelude shows a readiness for digital transformation, presenting sales opportunities in biotech software, cloud services, and cybersecurity solutions tailored for high-tech research environments.

Prelude Therapeutics Tech Stack

Prelude Therapeutics uses 8 technology products and services including WordPress, Hyperion, jQuery, and more. Explore Prelude Therapeutics's tech stack below.

  • WordPress
    Content Management System
  • Hyperion
    Corporate Performance Management
  • jQuery
    Javascript Libraries
  • SAP Maintenance, Repair, and Overhaul
    Operations
  • Cloudflare Bot Management
    Security
  • Google Tag Manager
    Tag Management
  • Bootstrap
    UI Frameworks
  • X-Content-Type-Options
    Web & Portal Technology

Media & News

Prelude Therapeutics's Email Address Formats

Prelude Therapeutics uses at least 1 format(s):
Prelude Therapeutics Email FormatsExamplePercentage
FLast@preludetx.comJDoe@preludetx.com
93%
Last@preludetx.comDoe@preludetx.com
5%
FL@preludetx.comJD@preludetx.com
1%
Middle@preludetx.comMichael@preludetx.com
1%

Frequently Asked Questions

Where is Prelude Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Prelude Therapeutics's main headquarters is located at 175 Innovation Boulevard Wilmington, Delaware 19805 United States. The company has employees across 2 continents, including North AmericaEurope.

What is Prelude Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Prelude Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Prelude Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Prelude Therapeutics is a publicly traded company; the company's stock symbol is PRLD.

What is Prelude Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Prelude Therapeutics's official website is preludetx.com and has social profiles on LinkedIn.

What is Prelude Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Prelude Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Prelude Therapeutics have currently?

Minus sign iconPlus sign icon
As of April 2026, Prelude Therapeutics has approximately 111 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer And Founder: K. V.Chief Medical Officer: C. M.Chief People Officer: M. P.. Explore Prelude Therapeutics's employee directory with LeadIQ.

What industry does Prelude Therapeutics belong to?

Minus sign iconPlus sign icon
Prelude Therapeutics operates in the Biotechnology Research industry.

What technology does Prelude Therapeutics use?

Minus sign iconPlus sign icon
Prelude Therapeutics's tech stack includes WordPressHyperionjQuerySAP Maintenance, Repair, and OverhaulCloudflare Bot ManagementGoogle Tag ManagerBootstrapX-Content-Type-Options.

What is Prelude Therapeutics's email format?

Minus sign iconPlus sign icon
Prelude Therapeutics's email format typically follows the pattern of FLast@preludetx.com. Find more Prelude Therapeutics email formats with LeadIQ.

When was Prelude Therapeutics founded?

Minus sign iconPlus sign icon
Prelude Therapeutics was founded in 2016.

Prelude Therapeutics

Biotechnology ResearchDelaware, United States51-200 Employees

Prelude Therapeutics is a leading precision oncology company developing innovative medicines in areas of high unmet need for cancer patients. Our pipeline features highly selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors – new approaches to clinically validated targets with transformative potential for patients. We are also leveraging our expertise in targeted protein degradation to discover and develop next generation degrader antibody conjugates (DACs) with novel payloads. We are on a mission to extend the promise of precision medicine to every cancer patient in need.

Section iconCompany Overview

Headquarters
175 Innovation Boulevard Wilmington, Delaware 19805 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
PRLD
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $25M$50M

    Prelude Therapeutics's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $25M$50M

    Prelude Therapeutics's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.